Abstracts - faqs.org

Abstracts

Business

Search abstracts:
Abstracts » Business

When stock-picking doesn't matter

Article Abstract:

Investors should focus more on market direction and less on the fundamentals of shares. Shares' betas, which measure sensitivity to returns on the All-Share index, can be good predictors of returns. Investors should choose low-beta shares in a declining market and high-beta ones in a rising market.

Publisher: FT Business
Publication Name: Investors Chronicle
Subject: Business
ISSN: 0261-3115
Year: 2001

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Beware of appearances

Article Abstract:

The image a company projects to investors offers little insight into whether its share performance will be good or bad. Many facts and inferences could be used to support either a bullish or a bearish outlook.

Publisher: FT Business
Publication Name: Investors Chronicle
Subject: Business
ISSN: 0261-3115
Year: 2001
Other Electrical Equipment and Component Manufacturing, Electronic Components and Accessories, Electronic Components, Securities, Electronic components industry, Filtronic Components Ltd.

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA



Subjects list: Methods, Management, Portfolio management, Investments
Similar abstracts:
  • Abstracts: Chinese walls. Outward appearances. Living dangerously
  • Abstracts: SCi: playing the game. Share price recovery is warranted. EMC
  • Abstracts: Shape isn't everything. Ride the recession. Online and the road to success
  • Abstracts: The relation between audit pricing and audit contract type: a public sector analysis. On R&D capitalization and value relevance: a commentary
  • Abstracts: What are you paying for yours? The importance of levers. ITs a wonderful life
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.